Metairie, LA, United States of America

Gregory D Espenan



Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 103(Granted Patents)


Company Filing History:


Years Active: 2001-2003

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Gregory D. Espenan

Introduction

Gregory D. Espenan is a notable inventor based in Metairie, Louisiana. He has made significant contributions to the field of radiolabeled compounds, particularly in enhancing tissue accumulation for medical applications. With a total of 2 patents, his work has the potential to improve therapeutic outcomes in cancer treatment.

Latest Patents

One of Gregory D. Espenan's latest patents is a method to enhance tissue accumulation of radiolabeled compounds. This innovative technique involves the administration of a radioisotopic compound by infusion over a period greater than two hours, preferably exceeding twelve hours. This approach significantly increases the maximum radioactivity that accumulates in target cells. The efficacy of this method can be enhanced by approximately five times compared to prior bolus injection or short infusion methods. By improving the tumor to background ratio, this technique increases the actual radioligand accumulated inside target cells. It is applicable to any radiolabeled compound whose cellular uptake is limited by binding to a cellular receptor or transport protein. Once the radiolabeled compound is bound and internalized, the competition from unlabeled compounds is markedly decreased. The primary factor governing residence time after internalization is the physical half-life of the radioisotope, rather than the biological half-life.

Career Highlights

Gregory D. Espenan is affiliated with Louisiana State University and Agricultural & Mechanical College, where he continues to advance his research and innovations. His work is instrumental in bridging the gap between scientific research and practical medical applications.

Collaborations

Gregory has collaborated with Eugene A. Woltering, further enhancing the impact of his research in the field.

Conclusion

Gregory D. Espenan's contributions to the field of radiolabeled compounds demonstrate his commitment to innovation and improving medical treatments. His patents reflect a deep understanding of the complexities involved in enhancing therapeutic efficacy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…